(Reuters) -COVID-19 vaccine maker BioNTech said on Friday it was looking into building malaria and tuberculosis vaccine production sites in Rwanda and Senegal, narrowing its search for African ...

DAKAR, Senegal (AP) — Senegal and Rwanda have signed an agreement with German company BioNTech for the construction of its first start-to-finish factories to make messenger RNA vaccines in Africa.

A meeting was held on 27 August in Berlin on the sidelines of the G20 ‘Compact with Africa’ summit, which was organised by Germany. Around the negotiating table were, among others, Rwandan and ...

Congo and the Rwanda-backed rebel group M23 have signed a framework agreement for a peace deal. The agreement, signed on ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. DAKAR, Senegal (AP) — Senegal and Rwanda ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. DAKAR, Senegal (AP) — Senegal and Rwanda ...

FILE - In this Friday, Oct. 1, 2021 file photo, a woman receives her second Pfizer-BioNTech vaccine jab from a healthcare worker during the inaugural vaccination weekend drive in Katlehong, east of ...

FILE - In this March 2021 photo provided by Pfizer, a technician inspects filled vials of the Pfizer-BioNTech COVID-19 vaccine at the company's facility in Puurs, Belgium. Pfizer and Moderna have ...